AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04809818 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Multiple doses of Placebo administered by intravenous infusion
Study NCT04809818 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Loading and maintenance doses of Aspirin administered by oral
Study NCT04809818 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Description: Loading and maintenance doses of Clopidogrel administered by oral
Study NCT04809818 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban
Description: Multiple doses of Apixaban administered by oral
Study NCT04809818 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabigatran
Description: Multiple doses of Dabigatran administered by oral
Study NCT05562557 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Case Management
Description: Referrals to treatment, social services, and employment services
Study NCT05016310 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High Dose Vitamin D
Description: High dose vitamin D: Subjects will receive 50,000 IU vitamin D2 weekly x 16 weeks followed by 4,000 IU of vitamin D3 daily with a goal 25(OH)D level of ≥45 but ≤80 ng/mL.
Study NCT05016310 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care Vitamin D
Description: Standard of Care Vitamin D: Vitamin D will be supplemented to 25(OH)D levels, with a goal 25(OH)D level of >30 ng/mL according to Endocrine Society Practice Guidelines.
Study NCT05964907 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Light Source B: Visible Light solar simulator (VL + UVA1)
Description: Patients will be radiated with light source B (Visible light solar simulator)
Study NCT05964907 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Light Source A: Visible Light solar simulator closer match to sunlight (VL +UVA1)
Description: Patients will be radiated with light source A (Visible light solar simulator closer match to sunlight)
Study NCT05746741 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth solution
Description: Video conferencing
Study NCT05860504 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardiography
Description: All patients in the study will be examined with echocardiography
Study NCT06165445 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial direct current stimulation (tDCS)
Description: In tDCS, direct electrical currents at the intensity of interest (2 mA for example) are generated by an electrical stimulator and are noninvasively delivered to the scalp through a pair of saline-soaked sponge electrodes (7×5 cm) or via more than two but smaller round electrodes over the target regions.
Study NCT06165445 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: transcranial direct current stimulation (tDCS)
Description: In tDCS, direct electrical currents at the intensity of interest (2 mA for example) are generated by an electrical stimulator and are noninvasively delivered to the scalp through a pair of saline-soaked sponge electrodes (7×5 cm) or via more than two but smaller round electrodes over the target regions.
Study NCT06165445 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: multichannel transcranial direct current stimulation (tDCS)
Description: In multichannel tDCS, direct electrical currents at the intensity of interest (2 mA for example) are generated by an electrical stimulator and are noninvasively delivered to the scalp through more than two and smaller round electrodes over the target regions.
Study NCT04354129 — intervention group
Intervention type: DRUG
Intervention: Cutaquig®
Description: Immunoglobulin replacement therapy with subcutaneous injections of Cutaquig® 165 mg/mL at home.
Study NCT06542484 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gefapixant Citrate
Description: An additional treatment of gefapixiant will be performed for 12 weeks.
Study NCT06648629 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Description: ACT is a trans-diagnostic treatment that targets experiential avoidance as an underlying factor common to mental and behavioral health problems. Mindfulness skills and values-guided behavioral action plans are used to decrease experiential avoidance and impact a broad array of psychological symptoms via improved psychological acceptance.
Study NCT06648629 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brief Alcohol Intervention
Description: The Brief Alcohol Intervention (BI) is a standard intervention for reducing alcohol use in PWH. The BI includes the creation of a drinking agreement, self-monitoring via drinking diary cards, discussion of risky moods/situation, and strategies for managing these moods/situations.
Study NCT04601428 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IA therapy of HCC with CSR02-Fab-TF
Description: Intra-Arterial Infusion of CSR02-Fab-TF
Study NCT06372522 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pitocin Injectable Product
Description: The primary dose of oxytocin is 1.0 mU/min, with an incremental increase by 2.5 mU/min every 30 minutes, until 20.0 mU/min, tittered to a target of 3-5 contractions in a 10-minute period, or active labor (dilatation > 6 cm).
Study NCT06372522 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pitocin Injectable Product
Description: The primary dose of oxytocin is 1.0 mU/min, with an incremental increase by 2.5 mU/min every 30 minutes, until 20.0 mU/min, tittered to a target of 3-5 contractions in a 10-minute period, or active labor (dilatation > 6 cm).
Study NCT04281225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attention to Variability (ATV)
Description: In Attention to Variability we ask the participant to attend to the natural fluctuations in mood and behavior that occur throughout the day, and to notice changes they experience with their hearing loss symptoms; noticing if it is better or worse and to ask why it may be.
Study NCT04281225 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants are told that the device they will be testing will improve their hearing, when in fact the device is not a hearing aid but just a metallic earring.
Study NCT04281225 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants are told that the device they will be testing will improve their hearing, when in fact the device is not a hearing aid but just a metallic earring.
Study NCT06137378 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KEYTRUDA®
Description: 200 mg KEYTRUDA® i. v. in 3-week cycle (q3w)
Study NCT04864626 — intervention group
Intervention type: OTHER
Intervention: semi-standardized interview
Description: annual collection of the number of consultations and hospitalizations at the center, as well as the number of treatments
Study NCT04864626 — intervention group
Intervention type: OTHER
Intervention: care experience questionary
Description: questionary with 12 questions to rate the quality of the telephone reception and your feelings during the interview
Study NCT04301076 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo tissue and blood sample collection
Study NCT04301076 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy
Study NCT04301076 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT or CT
Study NCT04301076 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT04301076 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin Hydrochloride
Description: Given IV
Study NCT04301076 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV
Study NCT04301076 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Given PO
Study NCT04301076 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study NCT04301076 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Given PO
Study NCT04301076 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine Sulfate
Description: Given IV
Study NCT06567730 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ni-ti Closed-coil Spring
Description: Ni-Ti closed-coil spring is a passive compressed spring made up of super elastic Nickel-titanium. Two eyelets are attached to each side of the coil to facilitate its application. The eyelets will be engaged in the hooks of the second premolar and canine brackets and will apply a force of 150 gm.
Study NCT06567730 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Elastomeric Power chain
Description: Elastomeric power chains are resilient and latex-free orthodontic materials. They are made up of elastic material and consist of many connected rings. Each ring is engaged in a bracket to apply a force of 175-300 gm.
Study NCT06252038 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Zoom Group Video (GV)
Description: Zoom delivery of the DPP. Participants have access to Prevent T2 Curriculum and connected technology to track weight and physical activity.
Study NCT06252038 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self Directed (SD)
Description: Self directed delivery of the DPP. Participants have access to online curriculum, lifestyle coach and connected technology to track weight and physical activity.
Study NCT05383274 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Optilume Urethral DCB
Description: The Optilume Drug Coated Balloon (DCB) is a guidewire compatible catheter with a tapered atraumatic tip. The distal end of the catheter has an inflatable balloon coated with a proprietary coating containing the drug paclitaxel that facilitates the drug's transfer to the urethral wall upon inflation.
Study NCT06559891 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TIVUS™ Renal Denervation System
Description: Renal artery catheterization procedure used to denervate the renal sympathetic nerves in the perivascular space using ultrasound energy.
Study NCT06559891 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: For those subjects randomized to the sham control, the angiogram will serve as the sham procedure.
Study NCT06655714 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT06654050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: alrizomadlin
Description: Alrizomadlin (APG-115) oral tablets (150 mg) taken every other day on Days 1, 3, 5, 7, 9, 11, and 13 of every cycle (1 cycle=21 days) for 8 cycles (i.e., Course 1). Individuals with stable or responding disease may receive an additional 8 cycles (i.e., Course 2). Maximum (total) of 2 treatment courses.
Study NCT06654245 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone based interview
Description: Receive SHAREDCare navigator calls
Study NCT06654245 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey using a questionnaire.
Description: Ancillary studies
Study NCT06654245 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic health record review
Description: Ancillary studies
Study NCT06654245 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Referral
Description: Receive standard of care automated referrals
Study NCT06655727 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound evaluation
Description: No intervention
Study NCT06588686 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buloxibutid
Description: Buloxibutid
Study NCT06588686 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06591819 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Hypofractionated Whole Pelvis Proton Therapy with Brachytherapy Boost
Description: Brachytherapy boost will be delivered and then whole pelvis proton radiation therapy in 5 fractions.
Study NCT06590441 — intervention group
Intervention type: DEVICE
Intervention: Myopia control spectacles
Description: Myopia control spectacles fitted with temperature sensors
Study NCT06602453 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GDC-8264
Description: GDC-8264 will be administered as per pre-defined regimen.
Study NCT06535230 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Manual anesthesia induction
Description: In manual anesthesia induction, anesthetic agents are administered at a fixed dose and rate adjusted according to the patient's weight
Study NCT06535230 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anesthesia induction with Target controlled infusions (TCI)
Description: Target controlled infusion (TCI) system aims to reach the theoretically targeted blood or brain concentration of anesthetic agents based on the patient's age, weight, and height, with computer-assisted algorithms.
Study NCT06535230 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hemodynamic monitoring with pressure recording analytical method (PRAM)
Description: The pulse contour device MostCare (Vytech, Vygon, Padova, Italy) provides functional hemodynamic monitoring using the pressure recording analytical method.
Study NCT05145764 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Suvorexant
Description: Encapsulated suvorexant (matched for color, weight, and size)
Study NCT05145764 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Encapsulated placebo (matched for color, weight, and size)
Study NCT05707078 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Neck dissection
Description: Based on PET/CT scan patients will undergo neck dissection.
Study NCT06076252 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Modified Blumgart Anastomosis in LPD
Description: This study is a clinical study designed by parallel control, the test group is LPD patients with modified Blumgart anastomosis and the control group is LPD patients with conventional Blumgart anastomosis
Study NCT06602453 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered as per pre-defined regimen.
Study NCT04672044 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active rTMS and exercise
Description: active
Study NCT06076252 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: conventional Blumgart anastomosis in LPD
Description: This study is a clinical study designed by parallel control, the test group is LPD patients with modified Blumgart anastomosis and the control group is LPD patients with conventional Blumgart anastomosis
Study NCT06154889 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: consultations with a psychologist
Description: Consultations with a sports psychologist to decrease kinesiophobia
Study NCT06154889 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional reeducation
Description: Conventional reeducation
Study NCT05470179 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hybrid hyrax distalizer
Description: class 2 Angle malocclusion
Study NCT04672044 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS+Exercise
Description: sham
Study NCT06302933 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Blood sampling
Description: Blood samples collected from children followed in the Pediacam III ANRS12225 cohort
Study NCT06655896 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rapcabtagene autoleucel
Description: single infusion of rapcabtagene autoleucel
Study NCT06655896 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: rituximab
Description: rituximab intravenous infusion (i.v.) as per protocol
Study NCT06002100 — intervention group
Intervention type: OTHER
Intervention: fNIRS measurement
Description: Kernel Flow2 measurements.
Study NCT06652568 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: ThinkSono System
Description: The ThinkSono Guidance System is a guidance software expected to help non-radiology specialist healthcare professionals produce compression ultrasound image data that meet or exceed the minimal image quality criteria for a remote diagnosis by an expert (e.g. radiologist).
Study NCT06606119 — intervention group
Intervention type: OTHER
Intervention: Data and tissue collection
Description: Collection of bone marrow, blood, feces, medical record data, and patient response surveys.
Study NCT06472622 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Thermal Pain Stimulation
Description: Thermal pain will be administered during fMRI neuroimaging via a thermal stimulation device (Medoc Ltd., Advanced Medical System, Israel; 510K: K052357; K041908; K922052) to examine brain activity corresponding to the experience of this stimulus. This device and associated system carries an FDA 510 (K) clearance.
Study NCT06472622 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Physical Effort Stimulation
Description: Physical effort will be administered during fMRI neuroimaging via a hand dynamometer attachment for a physiological monitoring system (BIOPAC Systems, Inc., Goleta, CA, USA) to examine brain activity corresponding to the experience of this stimulus. This device has not received pre-marked approval or 510 (K) clearance by the FDA.
Study NCT06604494 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: early feeding resumption
Description: Resumption of food on the 3rd or 4th day post-operatively with a mixed diet.
Study NCT06604494 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: late feeding resumption
Description: Resumption of food on the 7th day post-operatively with a mixed diet.
Study NCT06597734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine (AZA)
Description: Given by SC or IV
Study NCT06597734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: Given by IV
Study NCT06597734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olutasidenib
Description: Given by PO
Study NCT06597734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cedazuridine
Description: Given by PO
Study NCT05470179 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pendulum distalizer
Description: class 2 Angle malocclusion
Study NCT06655428 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endobronchial Therman Liquid Ablation (ETLA)
Description: The ETLA System is a minimally invasive bronchoscopic treatment designed to deliver heated normal saline to targeted emphysematous lung regions with hyperinflation to cause tissue ablation and subsequent volume reduction as a means for treating emphysema. The ETLA procedures will be performed under general anesthesia. Each procedure will be limited to treatment in a single lung, with either unilateral or bilateral treatment over the two procedures.
Study NCT06148012 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dental implant
Description: Digital panoramic radiographs taken during the patients' treatment periods (T0, T1) were used in the study. Measurements of marginal bone levels on radiographs were performed using the Image J software. The distance between the most coronal part of the implant neck and the most apical part of the defect caused by marginal bone loss was measured.~Fractal analysis (FA) was conducted on panoramic radiographs (OPG) with a size of 2952x1435 pixels and a depth of 32 bits. FA on these radiographs at T0 and T1 times was performed using the box counting method determined by White and Rudolp with the ImageJ program(23).
Study NCT05842265 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self acupressure
Description: patients will do self acupressure
Study NCT06657729 — intervention group
Intervention type: OTHER
Intervention: Succiometry
Description: Assessement of sucking performance by measuring pressures (suction, crushing) with a succiometer every 10 days. This instrument consists of a standard silicone teat for premature newborns, which is connected via two silicone tubes to pressure micro-sensors. These pressure sensors measure the child's sucking activity on the teat. This activity is characterised by suction and crushing movements. It is a non-nutritive sucking activity (no fluid is delivered). Sucking performance is recorded during a period of calm awakening of the infant and over a period of 5 minutes, and is part of routine care since non-nutritive sucking is a common practice in neonatal unit. The first measurement will be taken in the first week of life and then every 7-10 days until discharge from the neonatal unit.
Study NCT06657586 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: neuromuscular exercises
Description: The exercise was applied in 18 sessions of 6 weeks.The treatment program included coldpack from cold application agent, ultrasound (US) treatment and TENS application from electrotherapy methods.
Study NCT06657586 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conservative treatment
Description: The treatment program included coldpack from cold application agent, ultrasound (US) treatment and TENS application from electrotherapy methods.
Study NCT06656364 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Esprit BTK System
Description: The Esprit BTK System is a resorbable polymeric scaffold with the everolimus drug and a resorbable polymeric coating mounted on a balloon dilatation catheter.